Remdesivir: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Remdesivir. Educational only — not medical advice.
Labeled uses
VEKLURY is indicated for the treatment of coronavirus disease 2019 (COVID-19) in adults and pediatric patients (birth to less than 18 years of age weighing at least 1.5 kg) who are [see Clinical Studies (14) ] : Hospitalized, or Not hospitalized and have mild-to-moderate COVID-19, and are at high risk for progression to severe COVID-19, including hospitalization or death.
Source: FDA labeling via NIH DailyMed (set c0978fa8…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.